Dinan, T G, Majeed, T, Lavelle, E et al. · Psychoneuroendocrinology · 1997 · DOI
This study tested whether a specific brain chemical system called serotonin works properly in ME/CFS patients. Researchers gave patients and healthy people a medication that activates serotonin receptors, then measured how the body's stress-response system (the HPA axis) reacted. They found that ME/CFS patients had a weaker response than healthy people, suggesting this brain system doesn't function normally in ME/CFS.
This study provides mechanistic evidence that HPA axis dysfunction in ME/CFS may involve a specific neurochemical defect rather than being purely psychological. Understanding how serotonin signaling fails in ME/CFS could guide development of more targeted treatments and validates biological abnormalities in the condition.
This study does not prove that serotonin dysfunction is the primary cause of ME/CFS, only that it is associated with the condition. It does not establish whether this defect is present in all ME/CFS patients or whether it causes the fatigue symptoms directly. The findings are correlational and do not explain the downstream consequences of this blunted response.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.